Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -15.43% and 3.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?